Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Load”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04608214
What this trial is testing

Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19)

Who this might be right for
SARS-CoV-2
Assistance Publique - Hôpitaux de Paris 26
Not applicableStudy completedNCT03249493
What this trial is testing

Monitoring Of Viral Load In Decentralised Area in Vietnam

Who this might be right for
HIV/AIDSDried Blood SpotViral Load
Institut Pasteur 584
Early research (Phase 1)Study completedNCT00000849
What this trial is testing

Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 27
Not applicableStudy completedNCT03625258
What this trial is testing

Mutations of the Pre-core Region of Hepatite B Virus (HBV)

Who this might be right for
Hepatitis B Virus
Centre Hospitalier Universitaire, Amiens 200
Not applicableStudy completedNCT02153216
What this trial is testing

Formative Phase of Reducing Hazardous Alcohol Use & HIV Viral Load

Who this might be right for
Alcohol DrinkingAlcohol Use NormsAlcohol Use Among ART Clients
University of North Carolina, Chapel Hill 40
Testing effectiveness (Phase 2)UnknownNCT00951743
What this trial is testing

Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs)

Who this might be right for
HIV Infections
Rapid Laboratories Inc. 40
Not applicableStudy completedNCT00001089
What this trial is testing

HIV and Cytomegalovirus (CMV) in HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400
Testing effectiveness (Phase 2)Study completedNCT00158483
What this trial is testing

Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)

Who this might be right for
UlcerHerpes Genitalis
French National Agency for Research on AIDS and Viral Hepatitis 449
Testing effectiveness (Phase 2)UnknownNCT00002451
What this trial is testing

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 8
Not applicableStudy completedNCT00028366
What this trial is testing

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Early research (Phase 1)Study completedNCT00001118
What this trial is testing

Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT04517825
What this trial is testing

More Than a Machine: Make Point-of-care HIV-1 Viral Load Testing Effective in Rural Uganda

Who this might be right for
HIV-1-infection
University of North Carolina, Chapel Hill 242
Testing effectiveness (Phase 2)Study completedNCT00002233
What this trial is testing

A Combination of Four Drugs in Patients With Recent HIV Infection

Who this might be right for
HIV Infections
Glaxo Wellcome 30
Not applicableStudy completedNCT04794725
What this trial is testing

MOVIDA 1 Ter - Evaluation of the Cobas® Plasma Separation Card in the Field in Vietnam

Who this might be right for
HIV Infections
Institut Pasteur 250
Not applicableStudy completedNCT00000890
What this trial is testing

Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableUnknownNCT05311410
What this trial is testing

Viral Kinetics of SARS-CoV-2 in Patients With COVID-19 in the Intensive Care Unit Undergoing Dental Procedures

Who this might be right for
SARS-CoV2 InfectionViral LoadOral Diseases+1 more
University of Sao Paulo General Hospital 60
Not applicableStudy completedNCT00002197
What this trial is testing

1592U89 in HIV-Infected Children

Who this might be right for
HIV Infections
Glaxo Wellcome 250
Testing effectiveness (Phase 2)Study completedNCT00944541
What this trial is testing

Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration

Who this might be right for
HIV InfectionHIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 60
Large-scale testing (Phase 3)Ended earlyNCT04051970
What this trial is testing

Reducing Antiretroviral Treatments

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 360
Testing effectiveness (Phase 2)WithdrawnNCT04344236
What this trial is testing

Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19

Who this might be right for
COVID-19
NYU Langone Health
Next Page